Navigation Links
Neurotherapeutics presents special issue on new treatments for Alzheimer's disease
Date:7/24/2008

Chicago, 24 July 2008 The editors of Neurotherapeutics are pleased and proud to announce their July issue, devoted to "Novel Therapeutics for Alzheimer's Disease." Neurotherapeutics (http://www.neurotherapeutics.org/) is the journal of the American Society of Experimental NeuroTherapeutics (ASENT) www.asent.org.

The issue coincides with the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD), being held at McCormick Place, Chicago, July 26 to 31, 2008. Rudolph E. Tanzi, Ph.D., of the Massachusetts General Institute for Neurodegenerative Disease and Massachusetts General Hospital, is a Guest Editor. "In this issue of Neurotherapeutics, we have enlisted several experts in the field to review the most promising new therapeutics currently under development for the treatment and prevention of AD," Dr. Tanzi writes in the introductory editorial.

The eleven papers in the special issue highlight promising therapeutic targets for Alzheimer's disease, providing an update on efforts to develop treatments. Given the central role of amyloid β peptide (Aβ) in the pathogenesis of Alzheimer's disease, cerebral accumulations of Aβ are a major focus. The lead article in the issue looks at techniques for measuring the effects of disease-modifying therapies on cerebral Aβ levelsincluding the key question of whether they correlate with cognitive performance.

Clinical trials aimed at all of these therapeutic targets are underway. In his editorial, Dr. Tanzi expresses "cautious optimism and high hopes" that these trials may lead to new therapeutic approaches to Alzheimer's disease. He concludes, "With several active clinical trials and other promising drugs now headed toward the clinic, the hope is that we will soon have novel AD therapeutics that successfully slow or reverse disease progress in AD."


'/>"/>
Contact: Caroline Foote
c.foote@elsevier.com
215-239-3653
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
2. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
3. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
4. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008
5. OptiNose presents data on highly effective migraine treatment
6. International Association for Dental Research presents awards and fellowships
7. MIKE AND IKE(R) Lemonade Blends(TM) Presents $100,000 to Alexs Lemonade Stand Foundation
8. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
9. The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
10. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia
11. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... When struck with the aftermath of ... where to begin. The latest eBook released by ... offers accident victims a clear and concise process for ... their personal injury claim is seen through to successful ... actions that should be taken immediately following the trucking ...
(Date:3/27/2015)... 2015 Trail mix is the perfect, healthy ... weekend hikes and during the game! It’s portable, lightweight and ... proud to introduce a new line of specialty trail mixes ... and flavorful selections packed with nutritious, 100% all natural ingredients. ... grains that add protein and fiber to your diet and ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Approximately ... for Healthy Kids Coalition Lobby Day to lobby ... Health Improvement Program (SHIP). Everlast Climbing was ... PE Bill SF343/HF498 which would strengthen physical education ... student assessments and other measures to strengthen physical ...
(Date:3/27/2015)... 27, 2015 Since September 2014, the country ... comeback tour after having been in retirement for a period ... the performer to return to touring, and concert events have ... Omaha will likely sell out for the two shows recently ... to view the inventory of discounted Garth Brooks tickets ...
(Date:3/27/2015)... Canadian Cannabis Clinics ( http://www.cannabisclinics.ca ... utilization of medical cannabis as a treatment for ... and clinics dedicated to providing access to safe ... for patients searching for medical marijuana treatment in ... their sub domain for Canada. , With ...
Breaking Medicine News(10 mins):Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Canadian Cannabis Clinics (CCC) to Join the Canada.MarijuanaDoctors.com Network 2
... for regulating the immune system, an international team of ... that have the potential to treat diseases involving inflammation, ... The team started by creating a three-dimensional map of ... on the surface of human cells and plays a ...
... HealthDay Reporter , MONDAY, May 14 (HealthDay News) -- ... may help relieve shortness of breath during activity, Japanese ... that makes it hard to breathe; it is commonly ... "The effects of acupuncture are large," said Dr. George ...
... , SUNDAY, May 13 (HealthDay News) -- A new type ... people who have lost their vision due to degenerative eye ... research with rats. The system uses tiny solar panel-like ... a specially designed pair of goggles equipped with a miniature ...
... study has found that, contrary to current thinking, taking beta ... person,s risk of developing colorectal cancer. Published early online in ... Society, the study also revealed that even long-term use or ... risk. In recent years, researchers have thought that beta ...
... May 10 (HealthDay News) -- An advisory panel to the ... the weight-loss medication lorcaserin, even though concerns remain about cardiovascular ... nod to the drug, lorcaserin would become the first new ... FDA is not bound to follow the advice of its ...
... cause of death among children under 5, according to a ... School of Public Health. They examined the distribution of child ... percent were attributable to infectious causes and 40 percent occurred ... of the Lancet , suggest a decline in the ...
Cached Medicine News:Health News:Novel drug candidates offer new route to controlling inflammation 2Health News:Novel drug candidates offer new route to controlling inflammation 3Health News:Acupuncture May Help Ease Symptoms of COPD 2Health News:Acupuncture May Help Ease Symptoms of COPD 3Health News:In Rat Study, Eye Device Shows Promise for Restoring Sight 2Health News:Blood pressure drugs don't protect against colorectal cancer 2Health News:FDA Panel Gives Blessing to New Weight-Loss Drug 2Health News:Pneumonia and preterm birth complications are the leading causes of childhood death 2
(Date:3/27/2015)... 2015  Delcath Systems, Inc. (NASDAQ: DCTH ... focused on oncology with an emphasis on the ... the reporting of data from a single -center ... with the Delcath Hepatic Delivery System (Melphalan/HDS) and ... Society of Surgical Oncology (SSO) Annual Meeting 2015.  ...
(Date:3/27/2015)... , March 27, 2015  WebMD Health ... source of health information, today announced an ... National Action Plan for Combating Antibiotic-Resistant ... emphasized the urgency and importance of addressing ... and global health.    The WebMD ...
(Date:3/26/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... therapies for cardiovascular disease and overall health, announced that ... of the Corporation (the "Common Shares"). The Common Shares ... 5 th , 2014 to March 4 th , ... on or before April 1, 2015. Interest on the ...
Breaking Medicine Technology:Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
Inquire...
Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
... BD Vacutainer® SST™ ... and a polymer gel ... are used for serum ... also provide an efficient ...
Medicine Products: